Opendata, web and dolomites

BPET

The Next-Generation of Small, Cost-Effective and Mobile Brain Scanner for an Early Detection of Alzheimer’s Disease

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 BPET project word cloud

Explore the words cloud of the BPET project. It provides you a very rough idea of what is the project "BPET" about.

accelerate    scanner    founded    populations       positron    laboratory    larger    global    millions    hospitals    treatment    doctors    instead    start    lasting    drug    stage    scanners    alternative    alzheimer    emission    requested    detection    tools    tool    2030    shown    uses    swiss    company    profits    body    grow    programs    detect    people    bpet    5x    tomography    patients    tri    drying    tested    brain    10x    epidemic    positrigo    market    total    enabled    ce    efficient    room    marking    diminish    parallel    innovative    expensive    cohort    launch    hood    near    5m    treatments    2018    size    clinical    pet    industrial    healthcare    diagnostic    capacity    mobile    specially    neurodegenerative    burden    modal    expenses    accurate    76    boosting    acquire    scanning    first    hallmarks    diseases    live    filling    roi    follow    preliminary    complete    diagnosis    diverse    modifying    400    prototype    ad    capital    pave    sold    suffering    performance    validation   

Project "BPET" data sheet

The following table provides information about the project.

Coordinator
POSITRIGO AG 

Organization address
address: OTTO-STERN-WEG 5
city: ZURICH
postcode: 8093
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Switzerland [CH]
 Project website https://www.positrigo.com/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-02-01   to  2019-05-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    POSITRIGO AG CH (ZURICH) coordinator 50˙000.00

Map

 Project objective

Alzheimer’s (AD) is a global epidemic with 50 M people suffering it and 76 M expected by 2030 (related costs near $1 Tri in 2018). To diminish its burden, an early detection is crucial, specially when modifying treatments become available. The most accurate method to measure AD hallmarks is positron emission tomography (PET), but current PET scanners are multi-modal, whole-body, room-filling, expensive to acquire (€1-5 M) and not commonly used. Thus, there is still a need for more efficient diagnostic tools to detect AD at an early stage to adopt the best live-lasting treatment. Positrigo is a Swiss start-up, founded with the goal of provide an efficient PET tool for the early diagnosis of neurodegenerative diseases. Our technology has enabled us to develop a first prototype of BPET which has been preliminary tested in the laboratory with high performance. BPET is a dedicated mobile brain scanner with the size of a drying hood, 10x less capital (€400 k instead of millions) and 5x less operational expenses than current scanners. It will greatly improve early diagnosis of AD, facilitate its treatment follow-up and contribute to accelerate drug development programs, with a 10x increase in scanning capacity. BPET can be sold to hospitals and clinical research organizations, tailored to the needs of patients and doctors, and it can enable new case uses of brain PET (e.g many scanners used in parallel, wider populations, in larger cohort research studies). Diverse hospitals have shown their interest in BPET and their support for its complete development for its potential applications and impact. To launch BPET in the healthcare market we need its CE marking, clinical validation and industrial adaptation, so a total of €2.5M for phase 2 will be requested. BPET project will pave the way for our company to be established as an innovative alternative in scanner-based diagnosis, boosting our company to grow and reach around €30 M profits and a ROI of 7.4 after 5 years.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BPET" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "BPET" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

CoLumbo (2019)

AUTOMATED DIAGNOSTICS AND RADIOLOGICAL READING FROM LUMBAR SPINE MRI

Read More  

Nocturne (2019)

The eye as a window to the brain, extending lifelong brain health

Read More  

FIRESENSE (2019)

Flame Detector Based on Epitaxial Metal Oxides (EMO) Technology

Read More